跳至主要内容
临床试验/NCT02976181
NCT02976181已完成不适用

Registry to Improve the Adoption of Consensus Treatment Guideline (Brady MX)

Medtronic Cardiac Rhythm and Heart Failure5 个研究点 分布在 1 个国家目标入组 113 人开始时间: 2016年12月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
113
试验地点
5
主要终点
Absolute Change in the Proportion of Subjects Diagnosed With SND at Pre Specific Time.

研究概览

简要总结

Medtronic is sponsoring a quality improvement study called Brady MX. It is hypothesized that lack of awareness of treatment and diagnostics pathways result in lower number of referrals to implanters of IPG.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient at least 18 years of age
  • Patient´s heart rate meets at least one of the following:
  • Patient has a sinus rate ≤ 50 OR a junctional escape rhythm no faster than 50 Patient has a history of exercise intolerance
  • Patient complains of general fatigue, shortness of breath, shortness of breath with exertion, syncope, light headed dizziness, palpitations, lethargy, dyspnea OR malaise within the last 30 days that are not related to other discovered causes (such as untreated hypothyroidism or anemia)
  • Patient (or patient´s legally authorized representative) is willing and able to sign and date written Patient Consent Form/Data Release Form

排除标准

  • Patient has recent history of blood loss
  • Patient has a medical history leading to suspicion of neurological disorder
  • Patient has a history of Chronic Atrial Fibrilation
  • Patient is enrolled or planing to participate in a concurrent drug and/or device study at any time during the course of this clinical study without documented pre-approval from Medtronic study manager
  • Patient is not expected to survive 12 months
  • Patient is anticipated to be unwilling or unable to comply with the clinical investigation plan

结局指标

主要结局

Absolute Change in the Proportion of Subjects Diagnosed With SND at Pre Specific Time.

时间窗: 6 and 12 months

Because the study intervention was not conducted, it is not possible to compare the proportion of subjects with an SND diagnosis pre-intervention (Phase I) to the proportion post-intervention (Phase II). Instead, the proportion of subjects with an SND diagnosis in Phase I are reported

次要结局

  • Number of SND Subjects Receiving a Referral for an Indicated IPG Device After the Intervention(3, 6, and 15 months)

研究者

发起方
Medtronic Cardiac Rhythm and Heart Failure
申办方类型
Industry
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验

Brady MX a Quality Improvement Study | 临床试验